Symbol="TERN"
AssetType="Common Stock"
Name="Terns Pharmaceuticals Inc"
Description="Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of nonalcoholic steatohepatitis (NASH) and other chronic liver diseases. The company is headquartered in Foster City, California."
CIK="1831363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="343835000"
EBITDA="-79083000"
PERatio="None"
PEGRatio="None"
BookValue="4.489"
DividendPerShare="0"
DividendYield="0"
EPS="-1.16"
RevenuePerShareTTM="0.035"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.229"
ReturnOnEquityTTM="-0.35"
RevenueTTM="1000000"
GrossProfitTTM="1000000"
DilutedEPSTTM="-1.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="16.44"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="256.53"
PriceToBookRatio="1.339"
EVToRevenue="60.08"
EVToEBITDA="-1.033"
Beta="-1.11"
num_52WeekHigh="14.04"
num_52WeekLow="3.57"
num_50DayMovingAverage="7.72"
num_200DayMovingAverage="9.17"
SharesOutstanding="61072000"
DividendDate="None"
ExDividendDate="None"
symbol="TERN"
open="5.48"
high="5.58"
low="5.44"
price="5.48"
volume="227675.00"
latest_trading_day="2023-08-30"
previous_close="5.50"
change="-0.02"
change_percent="-0.3636%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="723954"
Change_recent_avg="-0.09"
Delta_recent_avg="0.75"
Variance_recent_avg="0.37"
Change_ratio_recent_avg="-1.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="1153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0186.jpeg"
image_negative_thumbnail_id_2="1103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="605"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
